Bavarian Nordic AS/ DK0015998017 /
2024-06-03 7:57:43 AM | Chg. +0.8400 | Volume | Bid10:00:00 PM | Ask10:00:00 PM | High | Low |
---|---|---|---|---|---|---|
24.6900EUR | +3.52% | - Turnover: - |
24.7800Bid Size: 170 | 25.1200Ask Size: 170 | 24.6900 | 24.6900 |
GlobeNewswire
05-31
Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Sm...
GlobeNewswire
04-29
Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chiku...
GlobeNewswire
02-23
Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines...
GlobeNewswire
2022-03-21
Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Com...
GlobeNewswire
2022-02-28
Bavarian Nordic Reports Additional Positive Phase 2 Results for its COVID-19 Vaccine Candidate Ahead...
GlobeNewswire
2022-02-14
Bavarian Nordic Announces Breakthrough Therapy Designation for its RSV Vaccine Candidate for the Pre...
GlobeNewswire
2021-12-06
Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening it...
GlobeNewswire
2021-12-05
Bavarian Nordic Reports Positive Topline Phase 2 Results for its COVID-19 Vaccine Candidate
GlobeNewswire
2021-09-01
Bavarian Nordic Reports Positive Results from Human Challenge Trial of its RSV Vaccine Candidate
GlobeNewswire
2021-08-23
Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of CO...
GlobeNewswire
2021-08-23
Bavarian Nordic Initiates Phase 2 Clinical Trial of COVID-19 Booster Vaccine
GlobeNewswire
2021-08-09
Bavarian Nordic Reports Initial Results from First-in-Human Trial of COVID-19 Vaccine
GlobeNewswire
2021-06-11
Bavarian Nordic Assists Public Health England in Response to New Cases of Monkeypox
GlobeNewswire
2021-03-08
Bavarian Nordic Reports Encouraging Preclinical Data for COVID-19 Vaccine Candidate Ahead of First-i...
GlobeNewswire
2020-12-16
Bavarian Nordic Secures Second Part of Smallpox Vaccine Order from the U.S. Government
GlobeNewswire
2020-08-24
Bavarian Nordic Announces Positive Topline Results from Phase 3 Clinical Study of Freeze-dried Small...
GlobeNewswire
2020-07-22
Bavarian Nordic and AdaptVac Sign Final License Agreement on COVID-19 Vaccine